Literature DB >> 21742723

Effects of an anti-platelet drug on the prevention of steroid-induced osteonecrosis in rabbits.

Ryosuke Yamaguchi1, Takuaki Yamamoto, Goro Motomura, Satoshi Ikemura, Kenyu Iwasaki, Garida Zhao, Yukihide Iwamoto.   

Abstract

OBJECTIVE: To investigate the effects of an anti-platelet drug (clopidogrel) on the prevention of steroid-induced osteonecrosis (ON) in rabbits.
METHODS: Adult male Japanese white rabbits were divided into two groups and treated as follows: one group received daily clopidogrel mixed in normal saline (AP; n = 35), the other received only normal saline (NS; n = 30). One week after the administration, all rabbits were injected once intramuscularly with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle. Three weeks after, both the femora and humeri were examined histopathologically for the presence of ON. The platelet aggregation assay and hematological examinations were performed before and after the steroid injection.
RESULTS: The incidence of ON in the AP group (48.5%) was significantly lower than that observed in the NS group (73.3%). The platelet aggregations in the AP group were significantly inhibited by the administration of clopidogrel. The levels of total cholesterol and triglycerides showed no significant differences between the AP and NS group.
CONCLUSION: The present experimental study demonstrated that the administration of an anti-platelet drug prevented steroid-induced ON in rabbits and that platelet aggregation seems to be one of the possible factors involved in the pathogenesis of steroid-induced ON.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742723     DOI: 10.1093/rheumatology/ker197

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

Review 1.  MRI-detected bone marrow changes within 3 weeks after initiation of high-dose corticosteroid therapy: a possible change preceding the subsequent appearance of low-intensity band in femoral head osteonecrosis.

Authors:  Yusuke Kubo; Takuaki Yamamoto; Goro Motomura; Nobuaki Tsukamoto; Kazuyuki Karasuyama; Kazuhiko Sonoda; Hiroyuki Hatanaka; Takeshi Utsunomiya; Yukihide Iwamoto
Journal:  Rheumatol Int       Date:  2015-08-22       Impact factor: 2.631

2.  Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults.

Authors: 
Journal:  Orthop Surg       Date:  2017-02       Impact factor: 2.071

Review 3.  Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review.

Authors:  Lei Zhao; Alan David Kaye; Aaron J Kaye; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

4.  Cholesterol- and lanolin-rich diets may protect against steroid-induced osteonecrosis in rabbits.

Authors:  Garida Zhao; Takuaki Yamamoto; Goro Motomura; Ryosuke Yamaguchi; Satoshi Ikemura; Kenyu Iwasaki; Yukihide Iwamoto
Journal:  Acta Orthop       Date:  2013-10-31       Impact factor: 3.717

5.  The impact of high total cholesterol and high low-density lipoprotein on avascular necrosis of the femoral head in low-energy femoral neck fractures.

Authors:  Xianshang Zeng; Ke Zhan; Lili Zhang; Dan Zeng; Weiguang Yu; Xinchao Zhang; Mingdong Zhao; Zhicheng Lai; Runzhen Chen
Journal:  J Orthop Surg Res       Date:  2017-02-17       Impact factor: 2.359

6.  Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity.

Authors:  Nancy E Lane; Geetha Mohan; Wei Yao; Kie Shidara; Yu-An Evan Lay; Jia Junjing; Alanna Dubrovsky; Donald B Kimmel
Journal:  Bone Rep       Date:  2018-11-03

Review 7.  Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version).

Authors:  Dewei Zhao; Feng Zhang; Benjie Wang; Baoyi Liu; Lu Li; Shin-Yoon Kim; Stuart B Goodman; Philippe Hernigou; Quanjun Cui; William C Lineaweaver; Jiake Xu; Wolf R Drescher; Ling Qin
Journal:  J Orthop Translat       Date:  2020-01-06       Impact factor: 5.191

8.  The proton pump inhibitor, lansoprazole, prevents the development of non-traumatic osteonecrosis of the femoral head: an experimental and prospective clinical trial.

Authors:  Ima Kosukegawa; Shunichiro Okazaki; Motohisa Yamamoto; Satoshi Nagoya; Chisako Suzuki; Junya Shimizu; Hiroki Takahashi; Toshihiko Yamashita
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-01-14

Review 9.  High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.

Authors:  Jose A Gómez-Puerta; Pilar Peris; Joan Carles Reverter; Gerard Espinosa; Angeles Martinez-Ferrer; Ana Monegal; Juan Monteagudo; Dolors Tàssies; Nuria Guañabens
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

10.  Different changes of microarchitectures of cortical and cancellous bones in sheep femoral head after long-term glucocorticoid interventions.

Authors:  Yuan-Hui Li; Fu-Qiang Gao; Li-Ming Cheng; Mian-Dong Zeng; Qin-Ye Qiu; Ming Ding
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.